Aim To analyse the association of human leukocyte antigen B27 with clinical and laboratory parameters in patients with juvenile idiopathic arthritis (JIA) at the disease onset. Methods A retrospective review of medical records of 25 HLAB27 positive and 25 HLA-B27 negative JIA patients was performed. The diagnosis of JIA was based on the 1997-2001 International League Against Rheumatism (ILAR) criteria. Collected data: age, sex, HLA- B27 antigen presence, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid-factor (RF), antinuclear antibody (ANA), fever, rash, uveitis, enthesitis, inflamed joints and subtype of JIA. Results HLA- B27 positive study group had more boys (p=0.01), higher erythrocyte sedimentation rate (p=0.038), higher presence of fever (p= 0.025) and enthesitis (p=0.024). Any significant difference in age of the disease onset, CRP, ANA, RF, rash, uveitis, inflamed joint and dactylitis was not noticed. The most common subtype of JIA in the HLA-B27 positive patients was ERA (60%). Conclusion This study showed that the presence of HLA- B27 antigen plays a significant role in determining the presenting clinical and laboratory characteristics in JIA patients.
Srivastava R, Phatak S, Yadav A, Bajpai P, Aggarwal A. HLA B27 typing in 511 children with juvenile idiopathic arthritis from India. Rheumatol Int. 2016;1407–11.
2.
Peltoniemi S, Nordal E, Lahdenne P, Aalto K. 8-year follow-up study: differences between HLA-B27 positive and negative children with juvenile idiopathic arthritis in Finland. Arthritis Rheumatol. 2015;10.
3.
Fisher C, Ciurtin C, Leandro M, Sen D, Wedderburn L. Similarities and Differences Between Juvenile and Adult Spondyloarthropathies. Front Med. 2021;16.
4.
Liu C, Raj S, Chen C, Hung K, Chou C, Chen I, et al. HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis. J Clin Invest. 2019;5357–73.
5.
Aschermann S, Englbrecht M, Bergua A, Spriewald B, Said-Nahal R, Breban M, et al. Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway. Joint Bone Spine. 2016;43–6.
6.
Coates L, Baraliakos X, Blanco F, Blanco-Morales E, Braun J, Chandran V, et al. The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care Res. 2021;856–60.
7.
Tay S, Yeo J, Leong J, Albani S, Arkachaisri T. Juvenile Spondyloarthritis: What more do we know about HLA-B27, enthesitis, and new bone formation? Front Med. 2021;666772.
8.
Chhabra A, Robinson C, Houghton K, Cabral D, Morishita K, Tucker L, et al. Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience. Rheumatology. 2020;3727–30.
9.
Marino A, Weiss P, Brandon T, Lerman M. Juvenile Spondyloarthritis: focus on uveitis. Pediatr Rheumatol Online J. 2020;70.
10.
Guo R, Cao L, Kong X, Liu X, Xue H, Shen L, et al. Fever as an initial manifestation of enthesitis-related arthritis subtype of juvenile idiopathic arthritis: retrospective study. PLoS One. 2015;1–6.
11.
Berntson L, Nordal E, Aalto K. HLA-B27 predicts a more chronic disease course in an 8-year follow up cohort of patients with juvenile idiopathic arthritis. J Rheumatol. 2013;725–31.
12.
Cassidy J, Pett R. Textbook of Pediatric Rheumatology. 2005;206–300.
13.
Goirand M, Breton S, Chevallier F, Duong N, Uettwiller F, Melki I, et al. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. Pediatr Rheumatol Online J. 2018;16–21.
14.
Żuber Z, Turowska-Heydel D, Sobczyk M, Chudek J. Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis. Reumatologia. 2015;125–30.
15.
Stanevicha V, Eglite J, Zavadska D, Sochnevs A, Lazareva A, Guseinova D, et al. HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia. Pediatr Rheumatol Online J. 2010;26.
16.
Chen B, Li J, He C, Li D, Tong W, Zou Y, et al. Role of HLA-B 27 in the pathogenesis of ankylosing spondylitis. Mol Med Rep. 2017;1943–51.
17.
Thomson W, Barrett J, Pepper D, Kennedy L, Ollier L, Silman W, et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations In UK patients. Rheumatology. 2002;1183–9.
18.
Hinks A, Cobb J, Marion M, Prahalad S, Sudman M, Bowes J, et al. Dense genotyping of immune loci in juvenile idiopathic arthritis identifies 14 new susceptibility loci. Nat Genet. 2013;664–9.
19.
Horton D, Shenoi S. Review of environmental factors and juvenile idiopathic arthritis. Open Access Rheumatol. 2019;253–67.
20.
Twilt M, Pradsgaard D, Spannow A, Horlyck A, Heuck C, Herlin T. Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2017;63.
21.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;767–78.
22.
Martini A, Ravelli A, Avcin T, Beresford M, Burgos-Vargas R, Cuttica R, et al. Pediatric Rheumatology International Trials Organization (PRIN-TO). Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2019;190–7.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
